Israel's Teva reaches opioid settlement in San Francisco
Company to pay 25 million dollars in cash and 20 million in supplies for overdose-reversal drugs after charges it fueled opioid epidemic but does not admit responsibility; hopes to settle U.S. nation liability by end of year